Customized phage therapies to eradicate
harmful bacteria in chronic diseases

Our phage therapy development and target discovery technologies were developed by world-leading scientists from top-tier institutions including MIT and the Weizmann Institute of Science
Learn about our technology

BiomX’s founders, management and investors all have a long history of excellence that is propelling us to continued success and innovation
Learn about our leadership team

BiomX News

Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.

Combined company renamed BiomX Inc. will trade on the NYSE American stock exchange under the symbol PHGE beginning October 29, 2019  NEW YORK and Ness Ziona, Israel, October 28, 2019 -- Chardan Healthcare Acquisition Corp. (NYSE: CHAC), a special purpose acquisition...

OUR INVESTORS